Gene therapy

The outlook for gene editing in treating disease

WHO panel advises on governance of genome editing

VectorY Therapeutics targets misfolded proteins

A new paradigm for gene therapy

Addressing the challenges of gene therapy medicinal products

Purespring to develop gene therapies for the kidney

Integrated product development for ATMPs

A new paradigm for cancer therapy emerges

The role of base and prime editing in therapeutics

Gene-edited therapies produce first clinical data